Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
180 Life Sciences | ATNF | Jan 13, 2025 | 1.49 | -1.32 |
22nd Century Group | XXII | Jan 13, 2025 | 6.00 | +22.70 |
23andMe | ME | Jan 13, 2025 | 3.64 | -5.21 |
2seventy bio | TSVT | Jan 13, 2025 | 2.48 | -0.40 |
4D Molecular Therapeutics | FDMT | Jan 13, 2025 | 4.76 | -13.77 |
60 Degrees Pharmaceuticals | SXTP | Jan 13, 2025 | 0.92 | -12.36 |
AbbVie | ABBV | Jan 13, 2025 | 176.74 | +0.90 |
AbCellera Biologics | ABCL | Jan 13, 2025 | 3.00 | +2.74 |
Abeona Therapeutics | ABEO | Jan 13, 2025 | 5.61 | +1.08 |
Abivax SA - American Depositary Shares | ABVX | Jan 13, 2025 | 6.50 | +1.88 |
Absci | ABSI | Jan 13, 2025 | 2.85 | -0.18 |
ABVC Biopharma | ABVC | Jan 13, 2025 | 0.53 | -4.33 |
Ac Immune SA | ACIU | Jan 13, 2025 | 2.61 | -4.04 |
Acadia Pharmaceuticals | ACAD | Jan 13, 2025 | 17.90 | +3.71 |
Accel Entertainment | ACEL | Jan 13, 2025 | 10.36 | +0.97 |
Accelerate Diagnostics | AXDX | Jan 13, 2025 | 1.13 | -5.83 |
Acelyrin | SLRN | Jan 13, 2025 | 2.15 | +4.37 |
Achieve Life Sciences | ACHV | Jan 13, 2025 | 3.32 | -1.78 |
Achilles Therapeutics ADR | ACHL | Jan 13, 2025 | 1.16 | -2.11 |
Aclaris Therapeutics | ACRS | Jan 13, 2025 | 2.48 | +0.40 |
Acrivon Therapeutics | ACRV | Jan 13, 2025 | 5.51 | +0.73 |
Actinium Pharmaceuticals | ATNM | Jan 13, 2025 | 1.26 | -1.56 |
Actuate Therapeutics | ACTU | Jan 13, 2025 | 8.08 | -2.65 |
Acumen Pharmaceuticals | ABOS | Jan 13, 2025 | 1.59 | -3.64 |
Acurx Pharmaceuticals | ACXP | Jan 13, 2025 | 0.70 | -13.39 |
Adagene ADR | ADAG | Jan 13, 2025 | 1.78 | -8.01 |
Adagio Medical | ADGM | Jan 13, 2025 | 0.89 | -6.60 |
Adaptimmune Therapeutics ADR | ADAP | Jan 13, 2025 | 0.60 | -3.98 |
Adaptive Biotechnologies | ADPT | Jan 13, 2025 | 6.46 | -0.62 |
ADC Therapeutics SA | ADCT | Jan 13, 2025 | 1.72 | -8.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.